Table 2 P-calprotectin values for patients with infection, for different patient characteristics
Characteristics | Calprotectin (mg/L), median (IQR) |
|---|---|
Sex | |
Female (n = 124) | 2.1 (1.1–3.6) |
Male (n = 195) | 2.4 (1.3–3.9) |
Age, years | |
< 40 (n = 15) | 2.1 (0.8–3.7) |
41–65 (n = 91) | 2.3 (1.3–4.0) |
66–80 (n = 134) | 2.2 (1.2–3.5) |
> 81 (n = 79) | 2.2 (1.2–3.9) |
Delta-SOFA | |
0–1 (n = 58) | 1.8 (1.1–3.5) |
> 2–4 (n = 204) | 2.4 (1.3–3.9) |
> 4 (n = 57) | 2.1 (1.2–4.0) |
Source of infection | |
Respiratory tract (n = 126) | 2.6 (1.5–4.3) |
Urogenital (n = 69) | 2.2 (1.3–3.9) |
Intra-abdominal (n = 31) | 1.7 (0.9–3.3) |
Skin/joint/soft tissue (n = 39) | 2.3 (1.2–3.7) |
Comorbidity (Charlson score) | |
0–1 (n = 21) | 2.4 (1.3–6.0) |
2–5 (n = 162) | 2.2 (1.1–3.9) |
6–10 (n = 118) | 2.2 (1.2–3.6) |
> 10 (n = 19) | 3.0 (2.0–5.9) |
Sepsis status | |
Sepsis (n = 261) | 2.3 (1.3–4.9) |
Not sepsis (n = 58) | 1.8 (1.1–3.5) |
Death with in 28 days | |
Dead within 28 days (n = 28) | 3.1 (1.2–5.9) |
Lived after 28 days (n = 291) | 2.2 (1.2–3.8) |
Blood culture status | |
Positive blood culture (107) | 2.3 (1.2–3.9) |
Negative blood culture (212) | 2.2 (1.2–3.8) |
Immunosuppressiona | |
Yes (46) | 1.8 (1.2–2.9) |
No (273) | 2.3 (1.2–3.9) |